Enantiomers of warfarin and vitamin K1 metabolism. 1986

I A Choonara, and B P Haynes, and S Cholerton, and A M Breckenridge, and B K Park

The effect of the individual enantiomers of warfarin at steady state (1 mg daily) was investigated in five healthy volunteers. Both enantiomers produced a significant increase in prothrombin time, but the increase with S warfarin (1.8 +/- 0.8 s, mean +/- s.d.) was greater than with R warfarin (1.0 +/- 0.3 s), despite lower steady state plasma concentrations of S warfarin, due to its more rapid clearance. Following the administration of vitamin K1, the maximum plasma concentration and area under the plasma concentration time curve values for the metabolite vitamin K1 2,3-epoxide were greater after S warfarin than after R warfarin. The greater anticoagulant potency of S warfarin is reflected by a greater degree of inhibition of vitamin K1 epoxide reductase.

UI MeSH Term Description Entries
D010837 Vitamin K 1 A family of phylloquinones that contains a ring of 2-methyl-1,4-naphthoquinone and an isoprenoid side chain. Members of this group of vitamin K 1 have only one double bond on the proximal isoprene unit. Rich sources of vitamin K 1 include green plants, algae, and photosynthetic bacteria. Vitamin K1 has antihemorrhagic and prothrombogenic activity. Phylloquinone,Phytomenadione,Phytonadione,Aquamephyton,Konakion,Phyllohydroquinone,Vitamin K1
D011517 Prothrombin Time Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS. Quick Test,Russell's Viper Venom Time,Thrombotest,Russell Viper Venom Time,Russells Viper Venom Time,Prothrombin Times,Test, Quick,Time, Prothrombin,Times, Prothrombin
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D014859 Warfarin An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide. 4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one,Aldocumar,Apo-Warfarin,Coumadin,Coumadine,Gen-Warfarin,Marevan,Tedicumar,Warfant,Warfarin Potassium,Warfarin Sodium,Potassium, Warfarin,Sodium, Warfarin

Related Publications

I A Choonara, and B P Haynes, and S Cholerton, and A M Breckenridge, and B K Park
December 1974, Biochemical pharmacology,
I A Choonara, and B P Haynes, and S Cholerton, and A M Breckenridge, and B K Park
July 1979, The Journal of pharmacy and pharmacology,
I A Choonara, and B P Haynes, and S Cholerton, and A M Breckenridge, and B K Park
November 1981, Biochemical pharmacology,
I A Choonara, and B P Haynes, and S Cholerton, and A M Breckenridge, and B K Park
October 1978, Lancet (London, England),
I A Choonara, and B P Haynes, and S Cholerton, and A M Breckenridge, and B K Park
February 1979, Lancet (London, England),
I A Choonara, and B P Haynes, and S Cholerton, and A M Breckenridge, and B K Park
June 1979, Naunyn-Schmiedeberg's archives of pharmacology,
I A Choonara, and B P Haynes, and S Cholerton, and A M Breckenridge, and B K Park
January 1976, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition,
I A Choonara, and B P Haynes, and S Cholerton, and A M Breckenridge, and B K Park
May 1974, Molecular pharmacology,
I A Choonara, and B P Haynes, and S Cholerton, and A M Breckenridge, and B K Park
January 1996, The Annals of pharmacotherapy,
I A Choonara, and B P Haynes, and S Cholerton, and A M Breckenridge, and B K Park
June 1977, Clinical science and molecular medicine,
Copied contents to your clipboard!